Introduction
- The kidneys are also involved in promoting erythropoiesis and producing activated vitamin D
- erythropoiesis (red blood cell production)
- the kidneys produce a glycoprotein growth factor called erythropoietin (EPO)
- in hypoxia, there is less O2 being delivered to the kidneys
- this in turn causes the production of hypoxia-inducible factor-1α (HIF-1α) which acts on the fibroblasts in the renal cortex to transcribe EPO (increased EPO mRNA)
- EPO promotes the differentiation of proerythroblasts to eventually form into erythrocytes (red blood cells)
- note that one can commonly see anemia in patients with chronic renal failure since the functioning renal mass is decreased
- this is why recombinant human EPO is a treatment for anemia of chronic renal failure
- note that one can commonly see anemia in patients with chronic renal failure since the functioning renal mass is decreased
- EPO promotes the differentiation of proerythroblasts to eventually form into erythrocytes (red blood cells)
- this in turn causes the production of hypoxia-inducible factor-1α (HIF-1α) which acts on the fibroblasts in the renal cortex to transcribe EPO (increased EPO mRNA)
- in hypoxia, there is less O2 being delivered to the kidneys
- the kidneys produce a glycoprotein growth factor called erythropoietin (EPO)
- vitamin D production
- the kidneys contain an enzyme called 1α-hydroxylase
- 1α-hydroxylase catalyzes the hydroxylation (at the C1 position) of 25-hydroxycholecalciferol into 1,25-dihydroxycholecalciferol
- 1,25-dihydroxycholecalciferol is a physiologically active form of vitamin D
- in the kidney, 25-hydroxycholecalciferol can also be hydroxylated (at the C24 position) into 24,25-hydroxycholecalciferol, an inactive form of vitamin D
- 1α-hydroxylase is regulated by a number of factors such as
- plasma Ca2+ concentration
- a decrease in plasma Ca2+ increases 1α-hydroxylase activity
- parathyroid hormone
- increases 1α-hydroxylase activity
- plasma phosphate concentration
- a decrease in plasma phosphate increases 1α-hydroxylase activity
- plasma Ca2+ concentration
- 1,25-dihydroxycholecalciferol is a physiologically active form of vitamin D
- 1α-hydroxylase catalyzes the hydroxylation (at the C1 position) of 25-hydroxycholecalciferol into 1,25-dihydroxycholecalciferol
- the kidneys contain an enzyme called 1α-hydroxylase
- erythropoiesis (red blood cell production)
- Prostaglandins
- the kidneys locally produce prostaglandins (e.g., PGE2) that result in vasodilation of the afferent arteriole
- this in turn increases renal blood flow
- nonsteroidal antiinflammatory drugs (NSAIDs) impair prostaglandin synthesis
- the renoprotective effects of prostaglandins are loss in low blood volume states (e.g., hemorrhage)
- the kidneys locally produce prostaglandins (e.g., PGE2) that result in vasodilation of the afferent arteriole
- Dopamine
- low levels of dopamine dilates the renal arterioles and thus increases renal blood flow
- secreted by proximal tubular cells to promote natriuresis
- low levels of dopamine dilates the renal arterioles and thus increases renal blood flow